Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.04%18.66B | 17.86%69.5B | 27.78%17.43B | -13.86%58.97B | 0.06%15.84B | -7.38%16B | -24.26%13.49B | -22.24%13.64B | 22.77%68.46B | -1.73%15.83B |
| Cost of revenue | 2.28%11.44B | 13.37%43.53B | 38.43%11.19B | -4.12%38.4B | 15.06%10.6B | 12.41%10.99B | -17.29%8.73B | -23.09%8.08B | 22.55%40.05B | 2.47%9.21B |
| Gross profit | 15.56%7.21B | 26.24%25.97B | 12.30%6.24B | -27.59%20.57B | -20.81%5.24B | -33.17%5.01B | -34.40%4.76B | -20.98%5.56B | 23.09%28.41B | -7.04%6.62B |
| Operating expense | 8.05%2.52B | 2.65%9.74B | -1.39%2.33B | 0.09%9.49B | -0.31%2.38B | -0.36%2.37B | 0.08%2.37B | 0.98%2.36B | 17.82%9.48B | 2.02%2.39B |
| Operating profit | 20.03%4.69B | 46.43%16.23B | 22.43%3.91B | -41.45%11.08B | -32.40%2.86B | -48.38%2.65B | -51.15%2.39B | -31.93%3.19B | 25.91%18.93B | -11.48%4.23B |
| Net non-operating interest income (expenses) | 74.86%71.08M | 66.48%207.6M | -22.65%40.65M | -7.68%124.7M | -54.09%27.84M | -46.67%26.03M | -2.23%18.27M | 659.64%52.55M | 698.59%135.07M | 1,296.55%60.65M |
| Non-operating interest income | 41.44%103.87M | 37.64%339.12M | -2.26%73.44M | 82.41%246.37M | -0.03%60.63M | 21.25%59.18M | 175.16%51.42M | 986.14%75.14M | 698.59%135.07M | 1,296.55%60.65M |
| Non-operating interest expense | 0.00%32.79M | 8.09%131.52M | 45.17%32.79M | --121.68M | --32.79M | --33.15M | --33.15M | --22.59M | --0 | --0 |
| Net investment income | -168.46%-236.71M | -89.39%70.63M | -29.71%345.79M | 3.76%665.47M | 463.33%302.78M | 58.02%-230.21M | -79.03%100.97M | -24.84%491.93M | 47.21%641.33M | -79.49%53.75M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 58.31%-6.72M | -3.76%-12.73M | -153.32%-16.12M | -103.25%-12.27M | -161.72%-11.09M | -99.18%2.26M | -75.99%2.92M | -109.05%-6.36M | 69.61%377.91M | -86.82%17.96M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -72.93%2.1M | -368.81%-295.49M | 121.44%7.76M | 342.66%109.92M | 766.90%139.56M | 779.96%21.2M | 16.77%-14.64M | -885.76%-36.2M | -85.60%-45.3M | -338.98%-20.93M |
| Less:Impairment of capital assets | --0 | -21.64%851K | -12.17%267K | -64.84%1.09M | -55.54%257K | -65.59%256K | -69.04%269K | -66.15%304K | 17.32%3.09M | -15.99%578K |
| Less:Other special charges | 73.84%-2.1M | 365.42%294.64M | -122.36%-8.03M | -545.89%-111.01M | -4,709.69%-139.81M | -1,003.83%-21.46M | -14.05%14.37M | 1,193.91%35.89M | 14.34%24.9M | -25.64%3.03M |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --17.32M | ---- |
| Other non-operating income (expenses) | 11.30%10.96M | 93.86%66.74M | 36.80%9.85M | -19.40%34.42M | -11.33%7.28M | -27.51%9.85M | -1.73%10.1M | -32.33%7.2M | 51.52%42.71M | 11.25%8.21M |
| Income before tax | 5.49%4.53B | 35.49%16.27B | 16.07%4.3B | -40.22%12.01B | -23.53%3.32B | -49.64%2.47B | -53.54%2.5B | -31.82%3.7B | 27.80%20.08B | -16.09%4.35B |
| Income tax | 1.09%1.43B | 26.80%4.64B | 13.19%1.41B | -38.47%3.66B | -11.33%1.09B | -53.89%655M | -56.31%671.2M | -29.40%1.25B | 23.41%5.95B | -24.35%1.23B |
| Net income | 7.65%3.11B | 39.31%11.62B | 17.54%2.88B | -40.95%8.34B | -28.33%2.24B | -47.91%1.82B | -52.44%1.83B | -32.98%2.45B | 29.74%14.13B | -12.33%3.12B |
| Net income continuous operations | 7.65%3.11B | 39.31%11.62B | 17.54%2.88B | -40.95%8.34B | -28.33%2.24B | -47.91%1.82B | -52.44%1.83B | -32.98%2.45B | 29.74%14.13B | -12.33%3.12B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 7.65%3.11B | 39.31%11.62B | 17.54%2.88B | -40.95%8.34B | -28.33%2.24B | -47.91%1.82B | -52.44%1.83B | -32.98%2.45B | 29.74%14.13B | -12.33%3.12B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 7.65%3.11B | 39.31%11.62B | 17.54%2.88B | -40.95%8.34B | -28.33%2.24B | -47.91%1.82B | -52.44%1.83B | -32.98%2.45B | 29.74%14.13B | -12.33%3.12B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 7.63%88.07 | 39.28%329.68 | 17.52%81.83 | -40.96%236.7 | -28.34%63.45 | -47.92%51.61 | -52.44%52.01 | -32.98%69.63 | 30.13%400.9 | -12.25%88.54 |
| Diluted earnings per share | 7.63%88.07 | 39.28%329.68 | 17.52%81.83 | -40.96%236.7 | -28.34%63.45 | -47.92%51.61 | -52.45%52.0024 | -32.98%69.63 | 30.13%400.9 | -12.25%88.54 |
| Dividend per share | 0 | 10.61%73 | 0 | 4.76%66 | 0.00%33 | 0 | 10.00%33 | 0 | 14.55%63 | 10.00%33 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |